Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide (Q37201853)
Jump to navigation
Jump to search
scientific article published on 24 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide |
scientific article published on 24 December 2008 |
Statements
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide (English)
Judith E Karp
Karen Flatten
Eric J Feldman
Jacqueline M Greer
David A Loegering
Rebecca M Ricklis
Lawrence E Morris
Ellen Ritchie
B Douglas Smith
Valerie Ironside
Timothy Talbott
Gail Roboz
Son B Le
Xue Wei Meng
Paula A Schneider
Nga T Dai
Steven D Gore
Mark J Levis
John J Wright
Elizabeth Garrett-Mayer
24 December 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference